Michael Schwarzinger
Overview
Explore the profile of Michael Schwarzinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
1764
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schwarzinger M, Ferreira-Borges C, Neufeld M, Alla F, Rehm J
Lancet Public Health
. 2024 Jun;
9(7):e461-e469.
PMID: 38942557
Background: Even though alcohol consumption is an established risk factor for cancer, evidence regarding the effect of a reduction or cessation of alcohol consumption on cancer incidence is scarce. Our...
2.
Francis-Oliviero F, Constantinou P, Haneef R, Schwarzinger M, Gallay A, Rachas A, et al.
Lancet Reg Health Eur
. 2024 May;
39:100848.
PMID: 38803633
Background: France faces nowadays some major challenges regarding its health care system including medically underserved areas, social health inequalities, and hospital pressures. Various indicators and sources of data allow us...
3.
Tzedakis S, Yzhaky Shapira O, Schwarzinger M, Katsahian S, Lazzati A, Dohan A, et al.
Br J Surg
. 2023 Nov;
111(1).
PMID: 37951599
No abstract available.
4.
Schwarzinger M, Luchini S, Teschl M, Alla F, Mallet V, Rehm J
PLoS Med
. 2023 Feb;
20(2):e1004134.
PMID: 36745669
Background: Meta-analyses have shown that preexisting mental disorders may increase serious Coronavirus Disease 2019 (COVID-19) outcomes, especially mortality. However, most studies were conducted during the first months of the pandemic,...
5.
Bourreau C, Baron A, Schwarzinger M, Alla F, Cambon L, Donzel Godinot L, et al.
Vaccines (Basel)
. 2022 Oct;
10(10).
PMID: 36298526
COVID-19 vaccines are one of the best tools to limit the spread of the virus. However, vaccine hesitancy is increasing worldwide, and France is one of the most hesitant countries....
6.
Maertens J, Lodewyck T, Donnelly J, Chantepie S, Robin C, Blijlevens N, et al.
Clin Infect Dis
. 2022 Jul;
76(4):674-682.
PMID: 35906831
Background: Empiric antifungal therapy is considered the standard of care for high-risk neutropenic patients with persistent fever. The impact of a preemptive, diagnostic-driven approach based on galactomannan screening and chest...
7.
Schwarzinger M, Dufouil C
Lancet Public Health
. 2022 Jan;
7(2):e94-e95.
PMID: 34998486
No abstract available.
8.
Depret F, Bouam S, Schwarzinger M, Mallet V
J Hepatol
. 2021 Nov;
76(3):744-747.
PMID: 34838613
No abstract available.
9.
Velardo F, Watson V, Arwidson P, Alla F, Luchini S, Schwarzinger M, et al.
Vaccines (Basel)
. 2021 Nov;
9(11).
PMID: 34835295
It can be assumed that higher SARS-CoV-2 infection risk is associated with higher COVID-19 vaccination intentions, although evidence is scarce. In this large and representative survey of 6007 adults aged...
10.